Rona Therapeutics

Rona Therapeutics is a clinical-stage company focused on nucleic acid drug research and development, specializing in metabolic diseases and CNS degenerative diseases. They are advancing a pipeline of siRNA programs, with their first program, RN0191, completing Phase 1 clinical studies and ready for Phase 2. Rona utilizes a proprietary extra-hepatic delivery platform to treat complex diseases.

Buy Funded Startups lists

Funding Round: Series A+

Funding Amount: $35M

Date: 19-Jul-2024

Investors: LongRiver Investments, Zhaode Investment, BioTrack Capital, Zhongqi Capital, Lilly Asia Ventures

Markets: Biotechnology, Pharmaceuticals, RNA Therapeutics, Drug Discovery, Health Care, Medical, Therapeutics

HQ: Shanghai, Shanghai, China

Founded: 2021

Website: https://www.ronatherapeutics.com/

LinkedIn: https://www.linkedin.com/company/ronatherapeutics/

Twitter:

Instagram: